Consilium Wealth Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
3,722
+362
+11% +$367K 1.17% 22
2025
Q4
$3.61M Sell
3,360
-35
-1% -$33.5K 1.33% 22
2025
Q3
$2.59M Buy
3,395
+363
+12% +$270K 1% 25
2025
Q2
$2.36M Sell
3,032
-305
-9% -$237K 1% 24
2025
Q1
$2.76M Buy
3,337
+137
+4% +$114K 1.38% 20
2024
Q4
$2.47M Sell
3,200
-782
-20% -$648K 1.18% 23
2024
Q3
$3.53M Sell
3,982
-545
-12% -$490K 1.93% 15
2024
Q2
$4.1M Sell
4,527
-24
-0.5% -$19.2K 2.24% 14
2024
Q1
$3.54M Buy
4,551
+10
+0.2% +$7.12K 1.99% 17
2023
Q4
$2.65M Buy
4,541
+246
+6% +$144K 1.59% 19
2023
Q3
$2.31M Buy
4,295
+161
+4% +$83K 1.62% 19
2023
Q2
$1.94M Buy
4,134
+313
+8% +$131K 1.34% 19
2023
Q1
$1.31M Sell
3,821
-827
-18% -$279K 1.12% 18
2022
Q4
$1.7M Sell
4,648
-224
-5% -$79.4K 1.45% 16
2022
Q3
$1.57M Buy
4,872
+53
+1% +$16.8K 1.76% 14
2022
Q2
$1.56M Buy
4,819
+27
+0.6% +$8.11K 1.68% 17
2022
Q1
$1.37M Sell
4,792
-324
-6% -$83.4K 0.98% 25
2021
Q4
$1.41M Buy
+5,116
New +$1.3M 0.92% 24

Other funds holding LLY

Consilium Wealth Advisory's LLY Position: Q1 2026 in Review

Consilium Wealth Advisory increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $367K and bringing the position to 3,722 shares worth $3.42M. The position accounts for 1.17% of the portfolio, ranked #22.

Consilium Wealth Advisory first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.1M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Consilium Wealth Advisory held 3,722 shares of Eli Lilly worth $3.42M as of Q1 2026.
  • Consilium Wealth Advisory bought 362 Eli Lilly shares in Q1 2026, an estimated $367K.
  • Eli Lilly made up 1.17% of Consilium Wealth Advisory's portfolio in Q1 2026, its #22 holding.
  • Consilium Wealth Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Consilium Wealth Advisory's Eli Lilly position peaked at $4.1M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Consilium Wealth Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.